Diagnostic and prognostic value of Ischemia-modified albumin in patients with Crimean-Congo hemorrhagic fever

Journal of Medical Virology

Volumn 85, Issue 4, 2013, Pages 684-688

  Mentese, Ahmet ^a   Koksal, Iftihar ^a   Sumer, Aysegül Uzun ^a   Arslan, Mustafa ^a   Karahan, S Caner ^a   Yilmaz, Gürdal ^a  

^a KARADENIZ TECHNICAL UNIVERSITY   (Turkey)

Author keywords

Biomarker; CCHF; Hemorrhagic fever; IMA; Prognostic significance

Indexed keywords

ISCHEMIA MODIFIED ALBUMIN;

ADULT; ARTICLE; BLEEDING; COLORIMETRY; CONTROLLED STUDY; CRIMEAN CONGO HEMORRHAGIC FEVER; DIAGNOSTIC VALUE; FEMALE; HUMAN; ISCHEMIA; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PREDICTIVE VALUE; PROGNOSIS; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; BIOLOGICAL MARKERS; FEMALE; HEMORRHAGIC FEVER, CRIMEAN; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SERUM ALBUMIN;

EID: 84873973527     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.23521     Document Type: Article

References (33)

1. Bar-Or D, Lau E, Winkler JV. 2000. A novel assay for cobalt-albumin binding and its potential as a marker for myocardial ischemia-A preliminary report. J Emerg Med 19:311-315.
2. +) binding aminoacid residues of the N-terminus of human albumin. An insight into the mechanism of a new assay for myocardial ischemia. Eur J Biochem 268:42-47.
3. Berenshtein E, Mayer B, Goldberg C, Kitrossky N, Chevion M. 1997. Patterns of mobilization of copper and iron following myocardial ischemia: Possible predictive criteria for tissue injury. J Mol Cell Cardiol 29:3025-3034.
4. Bhagavan NV, Lai EM, Rios PA, Yang J, Ortega-Lopez AM, Shinoda H, Honda SA, Rios CN, Sugiyama CE, Ha CE. 2003. Evaluation of human serum albumin cobalt binding assay for the assessment of myocardial ischemia and myocardial infarction. Clin Chem 49:581-585.
5. Burt FJ, Swanepoel R, Shieh WJ, Smith JF, Leman PA, Greer PW, Coffield LM, Rollin PE, Ksiazek TG, Peters CJ, Zaki SR. 1997. Immunohistochemical and in situ localization of Crimean-Congo hemorrhagic fever (CCHF) virus in human tissues and implications for CCHF pathogenesis. Arch Pathol Lab Med 121:839-846.
6. Carattino MD, Cueva F, Zuccollo A, Monti JL, Navarro M, Catanzaro OL. 1999. Renal ischemia-induced increase in vascular permeability is limited by hypothermia. Immunopharmacology 43:241-248.
7. Celik B, Yardan T, Kefeli M, Mentese A, Turedi S, Baydin A, Karahan SC. 2012. Diagnostic value of ischaemia-modified albumin in pulmonary contusion in rats. Injury 43:357-361.
8. Christenson RH, Duh SH, Sanhai WR, Wu AH, Holtman V, Painter P, Branham E, Apple FS, Murakami M, Morris DL. 2001. Characteristics of an albumin cobalt binding test for assessment of acute coronary syndrome patients: A multicenter study. Clin Chem 47:464-470.
9. Cobbe SM, Poole-Wilson PA. 1980. The time of onset and severity of acidosis in myocardial ischemia. J Mol Cell Biol 12:745-760.
10. Connolly-Andersen AM, Moll G, Andersson C, Akerström S, Karlberg H, Douagi I, Mirazimi A. 2011. Crimean-Congo hemorrhagic fever virus activates endothelial cells. J Virol 85:7766-7774.
11. Ergonul O. 2006. Crimean-Congo haemorrhagic fever. Lancet Infect Dis 6:203-214.
12. Ergonul O, Celikbas A, Baykam N, Eren S, Dokuzoguz B. 2006. Analysis of risk-factors among patients with Crimean-Congo haemorrhagic fever virus infection: Severity criteria revisited. Clin Microbiol Infect 12:551-554.
13. Fagan GJ, Wayment H, Morris DL, Crosby PA. 2002. The albumin cobalt binding test: Analytical performance of a new automated chemistry assay for the detection of ischemia modified albumin (IMA). J Clin Ligand Assay 25:178-187.
14. Gunaydin NS, Aydin K, Yilmaz G, Caylan R, Koksal I. 2010. Crimean-Congo hemorrhagic fever cases in Eastern Black Sea Region of Turkey: Demographic, geographic, climatic, and clinical characteristics. Turk J Med Sci 40:829-834.
15. Gunduz A, Turedi S, Mentese A, Karahan SC, Hos G, Tatli O, Turan I, Ucar U, Russell RM, Topbas M. 2008a. Ischemia-modified albumin in the diagnosis of acute mesenteric ischemia: A preliminary study. Am J Emerg Med 26:202-205.
16. Gunduz A, Turedi S, Mentese A, Altunayoglu V, Turan I, Karahan SC, Topbas M, Aydin M, Eraydin I, Akcan B. 2008b. Ischemia-modified albumin levels in cerebrovascular accidents. Am J Emerg Med 26:874-878.
17. Hori S, Kyotani S, Inoue S, Fukuda K, Ohnishi Y, Kusuhara M, Aikawa N, Yamaguchi K, Nakamura Y, Handa S. 1991. Subepicardial microischemia formation induced by epicardial application of endothelin-1. J Cardiovasc Pharmacol 7:300-301.
18. 1H NMR spectroscopy. Biochemistry 23:2832-2838.
19. Lippi G, Montagnana M, Guidi GC. 2006. Albumin cobalt binding and ischemia modified albumin generation: An endogenous response to ischemia? Int J Cardiol 108:410-411.
20. McCord JM. 1985. Oxygen-derived free radicals in postischemic tissue injury. N Engl J Med 312:159-163.
21. Mentese A, Mentese U, Turedi S, Gunduz A, Karahan SC, Topbas M, Turan A, Patan T, Turkmen S, Okur G, Eminagaoglu MS. 2008. Effect of deep vein thrombosis on ischemia-modified albumin levels. Emerg Med J 25:811-814.
22. Mentese A, Turedi S, Turkmen S, Gunduz A, Uzun A, Kutlu O. 2011. Reply of the authors. Fertil Steril 95:e82-e83.
23. Mohanakrishnan P, Chignell CF, Cox RH. 1985. Chloride ion nuclear magnetic resonance spectroscopy probe studies of copper and nickel binding to serum albumins. J Pharm Sci 74:61-62.
24. Montagnana M, Lippi G, Volpe A, Salvagno GL, Biasi D, Caramaschi P, Cesare Guidi G. 2006. Evaluation of cardiac laboratory markers in patients with systemic sclerosis. Clin Biochem 39:913-917.
25. Ozkurt Z, Kiki I, Erol S, Erdem F, Yilmaz N, Parlak M, Gundogdu M, Tasyaran MA. 2006. Crimean-Congo hemorrhagic fever in Eastern Turkey: Clinical features, risk factors and efficacy of ribavirin therapy. J Infect 52:207-215.
26. Qu YZ, Li M, Zhao YL, Zhao ZW, Wei XY, Liu JP, Gao L, Gao GD. 2009. Astragaloside IV attenuates cerebral ischemia-reperfusion-induced increase in permeability of the blood-brain barrier in rats. Eur J Pharmacol 606:137-141.
27. Turedi S, Gunduz A, Menteşe A, Karahan SC, Yilmaz SE, Eroǧlu O, Nuhoglu I, Turan I, Topbas M. 2007. The value of ischemia-modified albumin in the diagnosis of pulmonary embolism. Am J Emerg Med 25:770-773.
28. Turedi S, Gunduz A, Mentese A, Dasdibi B, Karahan SC, Sahin A, Tuten G, Kopuz M, Alver A. 2009. Investigation of the possibility of using ischemia-modified albumin as a novel and early prognostic marker in cardiac arrest patients after cardiopulmonary resuscitation. Resuscitation 80:994-999.
29. Turk A, Nuhoglu I, Mentese A, Karahan SC, Erdol H, Erem C. 2011. The relationship between diabetic retinopathy and serum levels of ischemia-modified albumin and malondialdehyde. Retina 31:602-608.
30. Vestweber D. 2007. Adhesion and signaling molecules controlling the transmigration of leukocytes through endothelium. Immunol Rev 218:178-196.
31. Whitehouse CA. 2004. Crimean-Congo hemorrhagic fever. Antivir Res 64:144-160.
32. Yilmaz G, Koksal I, Topbas M, Yilmaz H, Aksoy F. 2010. The effectiveness of routine laboratory findings in determining disease severity in patients with Crimean-Congo hemorrhagic fever: Severity prediction criteria. J Clin Virol 47:361-365.
33. Zimmerman BJ, Granger DN. 1992. Reperfusion injury. Surg Clin North Am 72:65-83.